Intracranial Activity of Cabozantinib in MET Exon 14–Positive NSCLC with Brain Metastases
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Thoracic Oncology"
DOI: 10.1016/j.jtho.2016.09.127
Abstract: Introduction: A significant portion of NSCLCs with MET proto‐oncogene, receptor tyrosine kinase gene (MET) exon 14 skipping alterations are sensitive to small‐molecule mesenchymal‐epithelial transition tyrosine kinase inhibitors. However, the incidence and management of brain metastases… read more here.
Keywords: brain metastases; positive nsclc; exon positive; cabozantinib ... See more keywords